Inflammation Connected to Prostate Cancer
Inflamed tissue seems to play a crucial role in prostate cancer. The presence of inflamed tissue may suggest cancer, even when screening blood tests are not elevated and causing concern.
Cialis Falls Short in Preventing ED after Radiotherapy
Prostate cancer treatment is a common cause of erectile dysfunction (ED). A new study set out to see if tadalafil (Cialis, Adcirca) could prevent this post-treatment ED.
Discussing the Decision to Screen for Prostate Cancer
One test for prostate cancer — called PSA screening — has been controversial since it was first introduced. While the debate on prostate cancer screening continues, a recent review offers some insight on making the decision to get screened.
Rx for Prostate Cancer Not for All Men
Preventing the spread of prostate cancer to bones can mean fewer fractures and slower progression of cancer. One medication used for this purpose appears safe, but may not be effective in some patients.
Prostate Surgery May be Better Choice for Younger Men
There's some debate on how to handle early prostate cancer. While some doctors recommend surgery to remove the entire prostate, others advise waiting and monitoring to see if the disease advances.
BPA Exposure Linked to Prostate Cancer
Previous studies have found that a chemical commonly found in plastic products contributes to prostate cancer in animals. Does it have a role in human prostate cancer?
Impact of Exercise on Prostate Cancer Therapy Side Effects
Male hormones called androgens help prostate cancer develop, grow and spread. That’s why the disease is often treated with medications that block androgen activity.
How Painkillers Could Impact Prostate Cancer
One method of treating prostate cancer involves removing the entire prostate gland. The types of medications given during this surgery, a new study has found, may influence the course of the disease.
Inflammation May Signal Reduced Prostate Cancer Risks
The role inflammation plays in prostate cancer has been debated. Studies have shown inflammation increases and decreases prostate cancer risks. A new study suggests inflammation could be a good sign.
Candidate Rx Shows Promise for Certain Prostate Cancer
Male hormones, called androgens, drive prostate cancer. When used to treat prostate cancer, hormone therapy is designed to lower androgen levels. Once prostate cancer no longer responds to this treatment, it’s called castration- or castrate-resistant prostate cancer.